CorMedix Announces Changes to Lock-It-100, Phase 3 Clinical Trial in Hemodialysis Patients with CVCs 09/05/2018 iData Research Register to receive a free Vascular Access Devices and Accessories Market Report Suite for US 2018-2024 synopsis and brochure CorMedix Inc., a biopharmaceutical company focused on developing and com... Read More
